-
Lung cancer screening program won’t be in place this year as expected
19 Oct 2025 13:53 GMT
… content
“The earlier lung cancer is detected, like any cancer, the survivability percentage … for the implementation of the lung cancer screening program.
“The estimated … creation and implementation of the lung cancer screening program, which is designed …
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
19 Oct 2025 09:15 GMT
… is lung cancer? Available at: https://www.cancer.org/cancer/lung-cancer … : September 2025.
3American Lung Association. BRAF and lung cancer. Available at: https … www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer…
-
New Study Reveals COVID-19 mRNA Vaccine Triggers Immune Response That Could Combat Cancer
19 Oct 2025 14:43 GMT
… involved records of 180 advanced lung cancer patients who received a COVID … /Diseases and disorders/Cancer/Lung cancer
/Health and medicine … :
Image Credits:
Keywords
Tags: advanced lung cancer immunotherapycancer patient survival ratesCOVID-19 …
-
DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option
19 Oct 2025 14:05 GMT
… Deputy Chief Executive Officer, National Cancer Centre Singapore, and principal investigator … patients.
Unresectable or Metastatic Breast Cancer
In the pooled safety population … EGFR-Mutated Non-Small Cell Lung Cancer
TROPION-Lung05, TROPION-Lung01, TROPION …
-
<![CDATA[NaPi2b ADC TUB-040 Shows >50% ORR in Platinum-Resistant Ovarian Cancer]]>
19 Oct 2025 14:18 GMT
… high-grade serous ovarian cancer, according to findings … pretreated platinum-resistant ovarian cancer," principal investigator Antonio … with non–small cell lung cancer (NSCLC).
In the study … for platinum-resistant ovarian cancer, based on early promise …
-
The next cancer-fighting mRNA vaccine may already be here
19 Oct 2025 12:53 GMT
…
Researchers found that among cancer patients getting immunotherapy, those … advanced non-small cell lung cancer and got immunotherapy as … a promising area of cancer research. Scientists have … developed personalized mRNA cancer vaccines that are tailored …
-
Raludotatug Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Recurrent Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer in Phase 2 Part of REJOICE-Ovarian01 Phase 2/3 Trial
19 Oct 2025 14:05 GMT
… with advanced ovarian cancer will experience disease … Four (3.7%) interstitial lung disease (ILD)/pneumonitis … J Cancer. 2018; 9(5):872.
National Cancer Institute. Cancer Stat … Facts: Ovarian Cancer. Updated 2021 …
-
<![CDATA[PAM Inhibition Adds Value in HR+/HER2- PIK3CA Wild Type Advanced Breast Cancer]]>
19 Oct 2025 12:40 GMT
… wild-type advanced breast cancer following progression on, or … HER2-negative advanced breast cancer, the investigators aimed to … therapy for advanced breast cancer, measurable disease via … advanced breast cancer.
Patients were stratified by lung/liver …
-
Breakthrough Cancer Drug Stops Tumor Growth Safely, Protecting Healthy Cells
19 Oct 2025 13:15 GMT
… a major leap toward safer cancer treatments, scientists at the … In tests on mice with lung tumors driven by RAS … work together to create better cancer treatments.”
Dr. Matt Patricelli, … of targeted therapies that treat cancer more safely and effectively …
-
DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
19 Oct 2025 09:15 GMT
… Chief Executive Officer, National Cancer Centre Singapore, and Principal … EGFR-mutated non-small cell lung cancer (NSCLC) who have received … phase 3 trials in lung cancer and five phase 3 … EGFR-Mutated Non-Small Cell Lung Cancer
TROPION-Lung05, TROPION-Lung01, …
About
© 1995-2025